Korean drug makers in sales quagmire

Korean drug companies are trying to survive the government’s price cuts by slashing production costs and collaborating with foreign companies to sell products. But those measures have not been enough to stop a fall in sales, while the financial structure of local firm will further worsen due to low profit margins under unfair contract provisions.

According to a report for investors released ...